Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Event Contracts
New
Predict price moves and seize opportunities
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
CFD
Stock CFD Derivatives
US Stocks
0 Fee
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
JP Stocks
Top Japanese stocks, all in one place
Stock Futures
High leverage, 24/7 trading
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD Flexible US Treasury
3.8%
Earn reliable returns from treasury-backed RWAs
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
9.99%
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
$MRNA – Gate.io Expands Biotech Access with Moderna Perpetual Contracts
Gate.io has officially listed Moderna (MRNA) perpetual contracts in its Stock Contracts section . These USDT-settled contracts support leverage from 1x to 20x, allowing traders to gain exposure to the biotech giant without holding actual shares. This listing is part of Gate's multi-asset strategy, now covering over 12,500 global stocks and ETFs. For the #GateStockInsightsChallenge, this presents an opportunity to analyze MRNA's position in the mRNA vaccine space, its pipeline developments, and how biotech stocks respond to shifting regulatory and healthcare policies .